site stats

Biomarin pharmaceutical market cap

WebApr 13, 2024 · The business’s fifty day moving average price is $99.47 and its 200 day moving average price is $98.40. The firm has a market capitalization of $18.27 billion, a …

Insider Sell: Biomarin Pharmaceutical MarketScreener

WebBioMarin Pharmaceutical market cap as of February 03, 2024 is $20.81B . BioMarin Pharmaceutical market cap history and chart from 2010 to 2024. Market capitalization … WebApr 6, 2024 · About the company. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and … cyclops filament dryer https://htawa.net

Strs Ohio Sells 12,959 Shares of BioMarin Pharmaceutical Inc.

Web26 rows · Mar 22, 2024 · Biomarin Pharmaceutical Market Cap: 17.44B for March 29, 2024. Market Cap Chart. Historical Market Cap Data. View and export this data back to … WebApr 12, 2024 · The stock has a market capitalization of $18.25 billion, a PE ratio of 132.22 and a beta of 0.38. BioMarin Pharmaceutical ( NASDAQ:BMRN – Get Rating) last announced its quarterly earnings... WebGet the latest Biomarin Pharmaceutical Inc (BMRN) real-time quote, historical performance, charts, and other financial information to help you make more informed … cyclops fence energizer

BioMarin Pharmaceutical (BMRN) - Revenue

Category:Is Now A Good Time To Buy BioMarin Stock? The Motley Fool

Tags:Biomarin pharmaceutical market cap

Biomarin pharmaceutical market cap

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by …

WebJan 22, 2024 · Market Cap. $19B. Today's Change (-1.56%) -$1.55. Current Price ... That's why I like BioMarin Pharmaceutical (BMRN-1.56%), a biotech company founded in … WebMar 22, 2024 · BioMarin Pharmaceutical Inc. (BMRN) NASDAQ: BMRN · IEX Real-Time Price · USD. Add to Watchlist 90.08-2.00 (-2.17%) ... Profile; Chart; BMRN Market Cap. …

Biomarin pharmaceutical market cap

Did you know?

WebApr 9, 2024 · BioMarin Pharmaceutical Inc. has a 12-month low of $70.73 and a 12-month high of $117.77. The company has a market cap of $18.58 billion, a PE ratio of 134.59 and a beta of 0.38. The stock has a 50 day simple moving average of $100.53 and a 200-day simple moving average of $98.13. WebBioMarin Pharmaceutical Symbol: BMRNRank: #820Price: $111.81(-0.9128%) Market Cap: $20.7B($-189.6M)Industry: BiotechnologySector: HealthcareCountry: United StatesInsiders: 0.552%Institutions: 101.394% BioMarin Pharmaceutical Inc. Technicals 52 Week High: $114.8 52 Week Low: $70.73 50 Day MA: $99.43 200 Day MA: $88.59

WebApr 13, 2024 · The firm has a market capitalization of $18.27 billion, a PE ratio of 132.38 and a beta of 0.38. The business's fifty day moving average price is $99.47 and its 200 day moving average price is $98.40. The company has a debt-to-equity ratio of 0.24, a current ratio of 4.67 and a quick ratio of 3.15. WebApr 10, 2024 · BMRN Complete BioMarin Pharmaceutical Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. …

WebApr 13, 2024 · The company has a market cap of $18.27 billion, a price-to-earnings ratio of 132.38 and a beta of 0.38. BioMarin Pharmaceutical Inc. has a twelve month low of $70.73 and a twelve month high... WebApr 10, 2024 · BioMarin Pharmaceutical's mailing address is 770 Lindaro Street, San Rafael CA, 94901. The official website for the company is www.bmrn.com. The biotechnology company can be reached via phone …

WebBioMarin Pharmaceutical (BMRN) has a Smart Score of 9 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund …

WebApr 13, 2024 · The company has a market cap of $18.27 billion, a price-to-earnings ratio of 132.38 and a beta of 0.38. BioMarin Pharmaceutical Inc. has a twelve month low of … cyclops financeWebBioMarin to Host Fourth Quarter and Full-Year 2024 Financial Results Conference Call and Webcast on Monday, February 27, at 4:30 p.m. ET. January 8, 2024. BioMarin Announces Stable and Durable Annualized … cyclops fish minecraftWeb2 days ago · -- Jean Jacques Bienaime, Director, Chief Executive Officer, on April 10, 2024, sold 10,000 shares in Biomarin Pharmaceutical for $995,600. Following the Form 4 … cyclops femaleWebApr 13, 2024 · BioMarin Pharmaceutical Stock Performance NASDAQ:BMRN opened at $97.96 on Thursday. The firm has a market capitalization of $18.27 billion, a PE ratio of 132.38 and a beta of 0.38. The... cyclops figureWebBioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research … cyclops fence chargersWebApr 12, 2024 · BioMarin Pharmaceutical Inc. has a 12 month low of $70.73 and a 12 month high of $117.77. The company has a debt-to-equity ratio of 0.24, a current ratio of 4.67 and a quick ratio of 3.15. The business has a 50 day simple moving average of $99.85 and a 200-day simple moving average of $98.40. cyclops fisherWebBioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California.It has offices and facilities in the United States, South America, … cyclops film